Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients

BACKGROUND: Kidney transplant recipients (KTRs) receiving the mammalian target of rapamycin inhibitor sirolimus may display a reduced risk of skin cancer development compared to KTRs receiving calcineurin inhibitors. Despite studies investigating the effects of these 2 drug classes on T cells in pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Direct
Main Authors: Burke, Michael Thomas, Sambira Nahum, Lauren C., Isbel, Nicole M., Carroll, Robert P., Soyer, Hans Peter, Francis, Ross, Bridge, Jennifer Anne, Hawley, Carmel, Oliver, Kimberly, Staatz, Christine E., Wells, James William
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Kidney Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498012/
https://ncbi.nlm.nih.gov/pubmed/28706974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000694
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados